PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
21-Jan-2020 Exscientia appoints Dr. David Hallett as Chief Operating Officer as company positions for further growth Exscientia
21-Jan-2020 NORGINE WELCOMES NEW GENERAL MANAGER FOR GERMANY Norgine B.V.
21-Jan-2020 SMi’s Pharmaceutical Microbiology in Boston - what to expect over the 2 day conference SMi Group
20-Jan-2020 Chi-Med Announces that Surufatinib Phase III SANET-p Study Has Already Achieved its Primary Endpoint in Advanced Pancreatic Neuroendocrine Tumors in China and Will Stop Early Chi-Med
20-Jan-2020 Supporting progress of cell and gene therapy industrialisation with new aseptic manufacturing course FTI Consulting
20-Jan-2020 Positive update on the development of new XF‐platform drug formulations Destiny Pharma
20-Jan-2020 V-Bio Ventures invests in RootWave in a EUR 6.5 m Series A financing to develop and market electrical weed killing solutions V-Bio Ventures
20-Jan-2020 Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Synthorx Sanofi
20-Jan-2020 Unlawful changes to doctors’ pensions scrapped after BMA court victory The British Medical Association (BMA)
20-Jan-2020 TrakCel appoints Chief Product Officer to accelerate growth TrakCel
20-Jan-2020 Syndivia In-Licenses Novel Antibody Against Tumor-Specific Form of CD146 From SATT Sud-Est Syndivia
20-Jan-2020 Professor Trevor Jones, CBE, FMedSci, appointed chairman of the newly formed European Medicinal Cannabis Association The European Medicinal Cannabis Association (EUMCA)
20-Jan-2020 Pricing and reimbursement concern to remain the leading impediment to industry growth in 2020, says GlobalData GlobalData
20-Jan-2020 International Research Collaboration Reveals Promising Drug Candidate for Treatment of Blood Cancers International Research Collaboration
20-Jan-2020 PAA delivers flexible, safe, and reliable laboratory automation solutions at SLAS2020 Peak Analysis & Automation (PAA)
20-Jan-2020 Three clinical trials announced for Fasenra in eosinophil-driven skin diseases AstraZeneca
16-Jan-2020 IDT Partners With SOPHiA GENETICS to Increase Access to Clinical-grade Technologies Integrated DNA Technologies (IDT)
16-Jan-2020 The ICR responds to decision by NICE not to recommend pembrolizumab as first-line treatment for advanced head and neck cancer The Institute of Cancer Research
16-Jan-2020 Cunesoft GmbH joins forces with Phlexglobal Cunesoft GmbH
16-Jan-2020 PureTech Affiliate Akili Announces New AKL-T01 Study Achieved Primary Endpoint in Children with ADHD PureTech Health plc